TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

OMSAV PHARMA

Infectious Disease
Generics

OMSAV PHARMA is a generic drug manufacturer focused on Infectious Disease.

2023
Since
1
Drugs
-
Trials
4
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) 2025-03-21
Manufacturing (CMC)
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) 2024-06-20
Manufacturing (CMC)
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) 2024-05-09
Labeling
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) 2024-04-12
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 100%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease
Merck big-pharma
Infectious Disease
Baxter specialty
Infectious Disease
AbbVie big-pharma
Infectious Disease
Johnson & Johnson big-pharma
Infectious Disease